Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emanuela Fina
Observed names:
E. Fina,
Fina, Emanuela
Institution:
European Institute of Oncology
Observed institutions:
Mario Negri Sud Foundation,
IRCCS Ospedale San Raffaele,
Fondazione IRCCS Istituto Nazionale dei Tumori,
IRCCS Humanitas Research Hospital,
IRCCS San Raffaele Roma,
European Institute of Oncology
show all 6
ORCID:
0000-0002-9837-4320
Observed ORCID:
0000-0002-9837-4320
OpenAlex ID:
A5005962316
Works
35
Awards
4
Biomarkers and Lung Cancer Early Detection: State of the Art
2021
·
Elisa Dama
, Tommaso Colangelo
, et al.
·
Cancers
·
94
PDF
Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
2022
·
Emanuela Fina
, Loredana Cleris
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
55
Circulating Biomarkers for Prediction of Treatment Response
2015
·
V. Cappelletti
, V. Appierto
, et al.
·
JNCI Monographs
·
47
PDF
p38α Is Required for Ovarian Cancer Cell Metabolism and Survival
2010
·
Antonio Matrone
, Valentina Grossi
, et al.
·
International Journal of Gynecological Cancer
·
43
Did Circulating Tumor Cells Tell us all they Could? The Missed Circulating Tumor Cell Message in Breast Cancer
2015
·
Emanuela Fina
, Carolina Reduzzi
, et al.
·
The International Journal of Biological Markers
·
36
PDF
The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
2019
·
Loredana Cleris
, Maria Grazia Daidone
, et al.
·
Cells
·
29
PDF
Gene Expression Profiling of Circulating Tumor Cells in Breast Cancer
2014
·
Emanuela Fina
, Maurizio Callari
, et al.
·
Clinical Chemistry
·
24
Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma1
2016
·
Emanuela Fina
, Andrea Necchi
, et al.
·
Bladder Cancer
·
17
PDF
Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives
2025
·
Vincenzo Di Lauro
, Alessandro Rizzo
, et al.
·
Cancer Treatment Reviews
·
16
Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes
2022
·
Emanuela Fina
·
Cancers
·
14
PDF
Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer
2021
·
Emanuela Fina
, Davide Federico
, et al.
·
Cancers
·
13
PDF
Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
2017
·
Emanuela Fina
, Andrea Necchi
, et al.
·
Disease Markers
·
11
PDF
In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays
2015
·
Maurizio Callari
, Alessandro Guffanti
, et al.
·
Oncotarget
·
10
PDF
Liquid biopsy for guiding breast cancer immunotherapy
2025
·
Emanuela Fina
, Elsa Vitale
, et al.
·
Immunotherapy
·
6
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round
2024
·
Alberto Antonicelli
, Piergiorgio Muriana
, et al.
·
Cancers
·
4
PDF
Biological and Clinical Significance of Circulating Tumor Cells in Breast Cancer
2017
·
Fina, Emanuela
·
Open Research Online (The Open University)
·
3
Multigene assays in early breast cancer: Current evidence, limits and future directions
2026
·
Emanuela Fina
, Vincenzo Di Lauro
, et al.
·
Cancer Treatment Reviews
·
2
Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitors
2024
·
Carmelo Laface
, Emanuela Fina
, et al.
·
Expert Opinion on Biological Therapy
·
2
Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data
2024
·
Valentina Crippa
, Emanuela Fina
, et al.
·
BMC Bioinformatics
·
2
PDF
Quantification and molecular profiling of circulating tumor cells (CTCs) in urothelial cancer (UC) before and during systemic treatment: Implications across the clinical stages.
2014
·
Andrea Necchi
, Emanuela Fina
, et al.
·
Journal of Clinical Oncology
·
1
Phase II study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676).
2014
·
Andrea Necchi
, Patrizia Giannatempo
, et al.
·
Journal of Clinical Oncology
·
1
P1.15-01 Optimised Lung Cancer Screening to Prevent Cardiovascular and Pulmonary Diseases Coupled with Primary Prevention: Results of the Baseline Round
2023
·
G. Veronesi
, E. Bottoni
, et al.
·
Journal of Thoracic Oncology
PDF
Dataset related to article "Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer "
2022
·
Fina, Emanuela
, Federico, Davide
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
P22.03 Role of Circulating Tumor Cell Subpopulations in Operable Non-Small Cell Lung Cancer Diagnosis and Prognosis
2021
·
E. Fina
, D. Federico
, et al.
·
Journal of Thoracic Oncology
PDF
Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC)
2016
·
A. Necchi
, E. Fina
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
35
Citation count:
430
H-index:
11
I10-index:
13
Year
Topic
Type